Rocket Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 05/15/2025 | 17.69 M | $117.98 M | 0.00% | 16.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 12.63 M | $84.22 M | -9.78% | 11.47% |
| BLACKROCK, INC. | 05/02/2025 | 7.27 M | $48.52 M | 2.49% | 6.61% |
| VANGUARD GROUP INC | 05/09/2025 | 6.62 M | $44.14 M | 0.61% | 6.01% |
| MAVERICK CAPITAL LTD | 05/15/2025 | 5.20 M | $34.68 M | 0.01% | 4.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 05/09/2025 | 4.82 M | $32.15 M | 2.25% | 4.38% |
| STATE STREET CORP | 05/15/2025 | 3.71 M | $24.72 M | 7.15% | 3.37% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 3.50 M | $23.36 M | 36.43% | 3.18% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 3.29 M | $24.97 M | -17.81% | 2.99% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 3.04 M | $20.30 M | -3.33% | 2.76% |
| MORGAN STANLEY | 05/15/2025 | 2.64 M | $17.62 M | 123.00% | 2.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.99 M | $13.30 M | 13.75% | 1.81% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 1.62 M | $10.79 M | 58.57% | 1.47% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.51 M | $10.07 M | -63.40% | 1.37% |
| PROSIGHT MANAGEMENT, LP | 05/15/2025 | 1.48 M | $9.87 M | 35.94% | 1.34% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.32 M | $8.79 M | 0.00% | 1.20% |
| TORONTO DOMINION BANK | 05/15/2025 | 1.10 M | $7.34 M | 0.00% | 1.00% |
| NOVO HOLDINGS A/S | 05/15/2025 | 1.10 M | $7.34 M | 0.00% | 1.00% |
| BAKER BROS. ADVISORS LP | 05/15/2025 | 1.10 M | $7.32 M | 1,030.09% | 1.00% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.08 M | $7.20 M | -27.04% | 0.98% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 995.69 K | $6.64 M | 24.03% | 0.90% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 870.31 K | $5.80 M | 33.16% | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 850.00 K | $5.67 M | 13.33% | 0.77% |
| COMERICA BANK | 05/14/2025 | 815.99 K | $5.44 M | 4.56% | 0.74% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2025 | 770.69 K | $5.14 M | 0.00% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 747.15 K | $4.98 M | 121.77% | 0.68% |
| NORTHERN TRUST CORP | 05/13/2025 | 700.30 K | $4.67 M | 5.60% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 675.48 K | $4.51 M | 2.96% | 0.61% |
| WOODLINE PARTNERS LP | 05/15/2025 | 652.87 K | $4.35 M | 0.07% | 0.59% |
| UBS GROUP AG | 05/13/2025 | 647.83 K | $4.32 M | 13.66% | 0.59% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 629.75 K | $4.20 M | 100.00% | 0.57% |
| JPMORGAN CHASE & CO | 05/12/2025 | 610.09 K | $4.07 M | 18.34% | 0.55% |
| SIREN, L.L.C. | 05/23/2025 | 591.26 K | $3.94 M | -1.46% | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 577.49 K | $3.85 M | -24.11% | 0.52% |
| MYDA ADVISORS LLC | 05/14/2025 | 460.38 K | $3.07 M | 100.00% | 0.42% |
| MARSHALL WACE, LLP | 05/15/2025 | 438.62 K | $2.93 M | -3.97% | 0.40% |
| PRIVIUM FUND MANAGEMENT B.V. | 05/09/2025 | 432.76 K | $2.89 M | 8.83% | 0.39% |
| VOSS CAPITAL, LLC | 05/14/2025 | 432.24 K | $2.88 M | 2.50% | 0.39% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 421.49 K | $2.81 M | 87.90% | 0.38% |
| FEDERATED HERMES, INC. | 05/08/2025 | 414.50 K | $2.76 M | 100.00% | 0.38% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 413.55 K | $3.14 M | 0.00% | 0.38% |
| INVESCO LTD. | 05/12/2025 | 400.97 K | $2.67 M | 12.05% | 0.36% |
| M28 CAPITAL MANAGEMENT LP | 05/14/2025 | 385.68 K | $2.57 M | 0.00% | 0.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 352.96 K | $2.35 M | 100.00% | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 338.47 K | $2.26 M | 54.89% | 0.31% |
| 04/25/2025 | 323.09 K | $2.05 M | 114.30% | 0.29% | |
| WALLEYE CAPITAL LLC | 05/14/2025 | 287.09 K | $1.91 M | 30.41% | 0.26% |
| SYNOVUS FINANCIAL CORP | 05/14/2025 | 278.45 K | $1.86 M | 69.90% | 0.25% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 271.79 K | $1.81 M | 0.00% | 0.25% |
| NORDEA INVESTMENT MANAGEMENT AB | 05/14/2025 | 254.41 K | $1.67 M | 99.89% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rocket Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 287 institutional investors and hedge funds held shares of Rocket Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 17.69 M
WELLINGTON MANAGEMENT GROUP LLP: 12.63 M
BlackRock, Inc.: 7.27 M
VANGUARD GROUP INC: 6.62 M
MAVERICK CAPITAL LTD: 5.2 M
WESTFIELD CAPITAL MANAGEMENT CO LP: 4.82 M
97.72% of Rocket Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 253.93 M shares in the last 24 months. This purchase volume represents approximately $736.41 M in transactions.